Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Vong

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
La Revue De Medecine Interne|May 22, 2013
[An umbilical nodule]J Jacques, L Mesturoux, C Vong, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
Comparisons of Analysis Methods for Proof-of-Concept TrialsK E Karlsson, C Vong, M Bergstrand, et al.
Clinics and Research in Hepatology and Gastroenterology|January 28, 2014
Severe renal impairment during triple therapy with telaprevirP Carrier, T Chambaraud, C Vong, et al.
Journal of the American Chemical Society|September 9, 2020
Development of High-Specificity Fluorescent Probes to Enable Cannabinoid Type 2 Receptor Studies in Living CellsRoman C Sarott, Matthias V Westphal, Patrick Pfaff, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
La Revue De Medecine Interne|May 22, 2013
[An umbilical nodule]J Jacques, L Mesturoux, C Vong, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
Comparisons of Analysis Methods for Proof-of-Concept TrialsK E Karlsson, C Vong, M Bergstrand, et al.
Clinics and Research in Hepatology and Gastroenterology|January 28, 2014
Severe renal impairment during triple therapy with telaprevirP Carrier, T Chambaraud, C Vong, et al.
Journal of the American Chemical Society|September 9, 2020
Development of High-Specificity Fluorescent Probes to Enable Cannabinoid Type 2 Receptor Studies in Living CellsRoman C Sarott, Matthias V Westphal, Patrick Pfaff, et al.
Pageof 1